Shaily Engineering Plastics Limited · NSE:SHAILY
Shaily Engineering Plastics — Q2 FY27 Earnings Presentation
22 slides from Shaily Engineering Plastics's earnings presentation, Oct 29, 2026
Slide 1: Exchange filing cover letter for Q2 & H1 FY27 Investor Presentation
SEPL/SE/October/26-27 29th October 2026 The General Manager, The Manager, Corporate Relations/Listing Listing Department Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No. C/1, G Block, Floor 25, P.J. Towers, Bandra – Kurla Complex, Dalal Street, Bandra (E), Mum
Slide 2: Shaily Engineering Plastics Ltd. Investor Presentation
Shaily Engineering Plastics Ltd. Investor Presentation October 2026
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Shaily Engineering Plastics Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe f
Slide 4: Key Performance Highlights
Key Performance Highlights
Slide 5: Business Updates for Q2 FY27
Business Updates for Q2 FY27 Healthcare Consumer Semaglutide pens supply by the company Business confirmation received for • Two new contracts signed for IP led platforms • New product from an existing home furnishing customer Two-step Reusable Auto-Injector Pen launched for GLP-1 therapies • Increa
Slide 6: New Product Launch: Shaily AI Toby Reusable
New Product Launch : Shaily AI Toby Reusable Two-step reusable auto-injector platform for GLP-1 therapies Why it matters Compared with a fully disposable auto-injector Less material Only the Syringe Pod is single-use; the driver is reused Lower energy use Less device volume to manufacture for every
Slide 7: Key Consolidated Financial Highlights – Q2 & H1 FY27
Key Consolidated Financial Highlights – Q2 & H1 FY27 Revenues Gross Profit Margin EBITDA +70 bps +310 bps +24% +19% +25% +22% 319.5 600.2 59.3% 60.0% 55.3% 58.4% 101.8 185.1 256.7 503.3 81.6 152.0 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 EBITDA
Slide 8: Segment Wise Revenue Breakup
Segment Wise Revenue Breakup Revenue (Consumer) Revenue (Healthcare) Revenue (Industrial) TOTAL REVENUE Weaker Market Demand for Home Furnishings across +78% +23% +24% Q2 FY27 Europe & USA 175.1 28.6 319.5 -14% 23.2 256.7 98.6 134.9 115.9 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY
Slide 9: Operational Trends
Operational Trends +470 bps Revenue Analysis – Domestic vs. Exports 52.5% 47.8% The shift in the domestic-export mix is primarily due to the growing Healthcare business, where supplies to Indian pharma customers ultimately cater to global markets. Machine Utilization Across Plants (%) H1 FY26 H1 FY2
Slide 10: Efficient Use of Capital
Efficient Use of Capital RoCE RoE Fixed Asset Turnover Total Debt / Equity +530 bps +280 bps 41.1% 29.7% 2.0 0.3 26.9% 1.7 35.8% 0.2 Mar-26 Sep-26* Mar-26 Sep-26* Mar-26 Sep-26* Mar-26 Sep-26 On Consolidated Basis; *On Annualized basis 9
Slide 11: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Particulars (Rs. Crs.) Q2 FY27 Q2 FY26 Y-o-Y H1 FY27 H1 FY26 Y-o-Y Revenue 319.5 256.7 24% 600.2 503.3 19% Raw Material 127.7 104.5 249.5 225.0 Employee Expenses 34.8 26.3 67.6 51.2 Other Expenses* 59.9 46.5 102.9 79.5 Other Income 4.7 2.3 5.0 4.4 EBITDA 101.8 81
Slide 12: Consolidated Balance Sheet
Consolidated Balance Sheet Particulars (Rs. Crs.) Sep-26 Mar-26 Particulars (Rs. Crs.) Sep-26 Mar-26 Non-Current assets Equity Property, Plant and Equipments 612.7 574.0 Equity Share Capital 9.2 9.2 Capital Work in Process 29.5 28.8 Other Equity 825.5 707.5 Intangible assets 40.4 43.8 Total Equity 8
Slide 13: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Particulars (Rs. Crs.) Sep-26 Sep-25 Profit Before Tax 150.5 120.8 Adjustments 35.4 31.4 Operating profit before working capital changes 185.9 152.1 Changes in working capital -37.8 -24.9 Cash generated from operations 148.1 127.3 Direct taxes paid (net of refund) -3
Slide 14: About the Company
About the Company Enriching Lives Through Plastics Shaily Engineering Plastics Limited is India’s largest exporter of plastics components. Established in 1987, the Company provides end-to-end solutions in plastic products and services, whilst delivering superior quality and value to all stakeholders
Slide 15: Business Segments
Business Segments Consumer Industrial Healthcare ✓ Automotive Components ✓ Appliances ✓ Platform Devices ✓ LED Lights ✓ Home Furnishings ✓ High-Performance Engineering ✓ Toys ✓ Drug Delivery Devices ✓ FMCG Packaging Components ✓ Carbon Steel Furniture ✓ Pharma Packaging ✓ Consumer Electronics ✓ Semi
Slide 16: State-of-the-Art Manufacturing Facilities
State-of-the-Art Manufacturing Facilities 7 Facilities with over 200 molding machines ranging from 35 tons to 1,000 tons Rania ❖ Export Oriented Unit ❖ Pharma (Dedicated ISO Class 8 clean room manufacturing facility) ❖ Others Rania Halol GUJARAT Halol (GIDC) ❖ Automotive & Engineering Halol ❖ Carbon
Slide 17: Board of Directors
Board of Directors Executive Chairman Whole Time Director Managing Director Mr. Mahendra Sanghvi Mrs. Tilottama Sanghvi Mr. Amit Sanghvi Independent Director Executive Director Independent Director Dr. Shailesh Ayyangar Mr. Ranjit Singh Mr. Laxman Sanghvi Independent Director Independent Director Mr
Slide 18: Strong Credit Rating
Strong Credit Rating* Long and established track record in the plastic injection LONG TERM BANK FACILITIES molding business along with experienced Promoters Rs. 239.24 Crs. (reduced from Rs.239.62) Growth in Total operating income on the back of CARE A+ ; Outlook: Stable increased volumes & higher e
Slide 19: Consolidated Historical Profit & Loss Statement
Consolidated Historical Profit & Loss Statement Particulars (Rs. Crs.) FY26 FY25 FY24 FY23 Revenue 990.7 786.8 643.9 607.1 Raw Material 426.2 415.8 370.1 386.5 Employee Expenses 109.7 80.4 57.3 47.9 Other Expenses* 174.9 114.5 99.5 80.8 Other Income 7.8 2.3 6.5 4.5 EBITDA 287.7 178.4 123.4 96.4 EBIT
Slide 20: Consolidated Historical Balance Sheet
Consolidated Historical Balance Sheet Particulars (Rs. Crs.) Mar-26 Mar-25 Mar-24 Mar-23 Particulars (Rs. Crs.) Mar-26 Mar-25 Mar-24 Mar-23 Non-Current assets Equity Property, Plant and Equipments 574.0 459.1 435.4 347.9 Equity Share Capital 9.2 9.2 9.2 9.2 Capital Work in Process 28.8 17.4 15.3 49.
Slide 21: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Particulars (Rs. Crs.) FY26 FY25 FY24 FY23 Profit Before Tax 222.6 119.3 69.8 45.2 Adjustments 69.3 56.6 58.2 51.4 Operating profit before working capital changes 292.0 175.9 128.0 96.6 Changes in working capital -16.9 -48.3 -27.0 -0.6 Cash generated from operations
Slide 22: Contact
Contact Company : Investor Relations Advisors : Shaily Engineering Plastics Ltd. Strategic Growth Advisors Pvt. Ltd. CIN – L51900GJ1980PLC065554 CIN - U74140MH2010PTC204285 Mr. Sanjay Shah, Chief Strategy Officer Mr. Deven Dhruva / Ms. Krisha Shrimankar [email protected] [email protected] / kri
Shaily Engineering Plastics — Q2 FY27 Earnings Presentation on 6ix